-
公开(公告)号:US20210292338A1
公开(公告)日:2021-09-23
申请号:US17337570
申请日:2021-06-03
申请人: Yeda Research and Development Co. Ltd. , Universitat de Barcelona , Institució Catalana de Recerca I Estudis Avançats
IPC分类号: C07D498/04 , A61K45/06 , A61P35/00
摘要: Described herein are compounds having Formula I or Formula II: wherein each dashed line independently represents a saturated or unsaturated bond; R1 and R′1 are aryl or heteroaryl as defined herein; and R2 and R′2 are as defined herein. Further described is a method of inhibiting nuclear translocation of ERK1/2 in a cell, by contacting the cell with a compound having Formula I or Formula II. The compounds may also be for use in treating a disease or disorder associated with nuclear translocation of ERK1/2.
-
公开(公告)号:US20240208998A1
公开(公告)日:2024-06-27
申请号:US18556456
申请日:2022-04-21
申请人: FUNDACIÓ PRIVADA INSTITUT D'INVESTIGACIÓ ONCOLÓGICA DE VALL HEBRON , UNIVERSITAT DE BARCELONA , INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS
发明人: Héctor GARCÍA PALMER , Isabel PUIG BORREIL , Josep TABERNERO CATURLA , Carlos GALDEANO CANTADOR , Diego MUÑOZ-TORRERO LÓPEZ-IBARRA , Xavier BARRIL ALONSO , Sergio RUIZ CARMONA
IPC分类号: C07D513/04 , A61K31/427 , A61K31/429 , A61P35/00 , C07D417/14 , C07D519/00
CPC分类号: C07D513/04 , A61K31/427 , A61K31/429 , A61P35/00 , C07D417/14 , C07D519/00
摘要: The present invention relates to 2-aminothiazol or 2-aminooxazol derivatives or pharmaceutically acceptable salt thereof for use in the treatment of hyperproliferative disorders, to method of treatment and/or prevention of hyperproliferative disorders using said compounds and to a subgroup of said derivatives which are new.
-